These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 31988033)
1. Formulation development and in vitro evaluation of transferrin-conjugated liposomes as a carrier of ganciclovir targeting the retina. Asasutjarit R; Managit C; Phanaksri T; Treesuppharat W; Fuongfuchat A Int J Pharm; 2020 Mar; 577():119084. PubMed ID: 31988033 [TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment. Wang Q; Sun C; Xu B; Tu J; Shen Y Drug Deliv; 2018 Nov; 25(1):59-69. PubMed ID: 29228826 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067 [TBL] [Abstract][Full Text] [Related]
6. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial. Díaz-Llopis M; Martos MJ; España E; Cervera M; Vila AO; Navea A; Molina FJ; Romero FJ Doc Ophthalmol; 1992; 82(4):297-305. PubMed ID: 1339115 [TBL] [Abstract][Full Text] [Related]
7. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina. Kansara V; Hao Y; Mitra AK J Ocul Pharmacol Ther; 2007 Aug; 23(4):321-34. PubMed ID: 17803430 [TBL] [Abstract][Full Text] [Related]
8. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714 [TBL] [Abstract][Full Text] [Related]
9. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. Janoria KG; Boddu SH; Wang Z; Paturi DK; Samanta S; Pal D; Mitra AK J Ocul Pharmacol Ther; 2009 Feb; 25(1):39-49. PubMed ID: 19232011 [TBL] [Abstract][Full Text] [Related]
10. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation. Ju HY; Kang HJ; Hong CR; Lee JW; Kim H; Park KD; Shin HY; Park JD; Choi EH; Lee HJ; Ahn HS Transpl Infect Dis; 2016 Jun; 18(3):396-404. PubMed ID: 27041364 [TBL] [Abstract][Full Text] [Related]
11. Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV. Hoang QV; Simon DM; Kumar GN; Oh F; Goldstein DA Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):737-40. PubMed ID: 20094728 [TBL] [Abstract][Full Text] [Related]
12. Intraocular therapy for cytomegalovirus retinitis. Palestine AG J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527 [TBL] [Abstract][Full Text] [Related]
13. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270 [TBL] [Abstract][Full Text] [Related]
14. 3D printed ocusert laden with ultra-fluidic glycerosomes of ganciclovir for the management of ocular cytomegalovirus retinitis. Naguib MJ; Hassan YR; Abd-Elsalam WH Int J Pharm; 2021 Sep; 607():121010. PubMed ID: 34391852 [TBL] [Abstract][Full Text] [Related]
15. Assessment of ocular pharmacokinetics and safety of Ganciclovir loaded nanoformulations. Akhter S; Talegaonkar S; Khan ZI; Jain GK; Khar RK; Ahmad FJ J Biomed Nanotechnol; 2011 Feb; 7(1):144-5. PubMed ID: 21485843 [TBL] [Abstract][Full Text] [Related]
16. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS. Akula SK; Ma PE; Peyman GA; Rahimy MH; Hyslop NE; Janney A; Ashton P Br J Ophthalmol; 1994 Sep; 78(9):677-80. PubMed ID: 7947546 [TBL] [Abstract][Full Text] [Related]
17. Preparation of a TK/GCV administration system mediated by transferrin modified pro-cationic liposomes. Zhong ZR; Zhang ZR; Deng Y; Liu J; Song QG; Liu J; He Q Pharmazie; 2007 Jul; 62(7):522-7. PubMed ID: 17718194 [TBL] [Abstract][Full Text] [Related]
18. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Arevalo JF; Garcia RA; Mendoza AJ Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292 [TBL] [Abstract][Full Text] [Related]
19. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis]. Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241 [TBL] [Abstract][Full Text] [Related]
20. Ganciclovir delivery through an intravitreal microdialysis probe in rabbit. Waga J Acta Ophthalmol Scand; 2000 Jun; 78(3):369-71. PubMed ID: 10893076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]